CATALYST DOSSIER · UPDATED 2026-11-04
$CRVO
biotech · convergence 5 · conviction WATCH
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $CRVO?
Quantitative
Net Income (CY2026Q2) : $-6.6M (-5.0% YoY)
Catalysts
Multi-spoke convergence : 7 convergent signals fired: earnings, finra_short, sec_fda, auto_macro_adp_payrolls, auto_macro_durable_goods
Risks
Auditor change / restatement : going_concern on
Bear case
Squeeze unwind : Short interest can compress before retail catches the move — entry timing critical
Earnings binary : Print-day moves can swing ±15% — gap risk both directions
Sympathy basket (cerebro)
YOU via tech r=+0.86 sympathetic (score 31)
BLZE via tech r=+0.86 sympathetic (score 23)
KHC via staples r=-0.81 divergent (score 19)
REED via staples r=-0.81 divergent (score 16)
Q via semis r=+0.77 sympathetic (score 23)
DIOD via semis r=+0.77 sympathetic (score 18)
Signals Firing
earnings finra_short sec_fda auto_macro_adp_payrolls auto_macro_durable_goods auto_macro_fx_rates auto_macro_options_gex
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-10-14 sec_clean_gappers +0.9% -1.7% — 2026-10-14 sec_top_gappers +0.9% -1.7% — 2026-10-14 sec_top_moat_emerging +0.9% -1.7% — 2026-10-12 sec_top_gappers +0.8% -9.6% — 2026-10-12 sec_top_moat_emerging +0.8% -9.6% — 2026-10-09 sec_clean_gappers -13.4% -22.0% — 2026-10-09 sec_top_gappers -13.4% -22.0% — 2026-10-09 sec_top_moat_emerging -13.4% -22.0% —
Lifetime: 0/8 wins · hit-rate 0.0% on +2% intraday
Sympathy Basket YOU via tech · score 31 BLZE via tech · score 23 KHC via staples · score 19 REED via staples · score 16 Q via semis · score 23 DIOD via semis · score 18
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.